Financials
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 267 M162 M166 M178 M169 M129 M 642 M Research & development —————— — Operating income 73 M-197 M277 M148 M75 M-279 M 221 M Non-Operating Income, Total 6 M-36 M-39 M-37 M-45 M-38 M -159 M Interest expense, net of interest capitalized -10 M-12 M-9 M-8 M-8 M-10 M -35 M Non-Operating Income, excl. Interest Expenses 2 M-28 M-26 M-31 M-31 M-37 M -125 M Unusual income/expense 4 M-8 M-4 M2 M-6 M9 M 1 M Pretax income 79 M-233 M238 M111 M30 M-317 M 62 M Equity in earnings —————— — Taxes 8 M-67 M66 M38 M9 M-124 M -11 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 71 M-166 M172 M73 M21 M-193 M 73 M Discontinued operations —————— — Net income 71 M-166 M172 M73 M21 M-193 M 73 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 71 M-166 M172 M73 M21 M-193 M 73 M Basic earnings per share (Basic EPS) 0.57-1.351.450.630.12-1.69 0.51 Diluted earnings per share (Diluted EPS) 0.58-1.351.420.620.14-1.69 0.49 Average basic shares outstanding 126.14 M123.13 M118.85 M115.29 M118.17 M114.29 M — Diluted shares outstanding 128.37 M123.13 M120.93 M117.5 M119.93 M114.29 M — EBITDA 11.04 B-3 M476 M351 M274 M-75 M 1.03 B EBIT 10.85 B-197 M277 M148 M75 M-279 M 221 M Cost of revenue 314 M304 M342 M369 M344 M352 M 1.41 B Other cost of goods sold 314 M304 M342 M369 M344 M352 M 1.41 B Depreciation & amortization (cash flow) 190 M194 M199 M203 M199 M204 M 805 M